Celularity (CELU) Metrics: History & Chart

Celularity Inc.(CELU)

Biotechnology · Florham Park, NJ

$1.58-0.13 (-7.60%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Celularity Inc.

Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments are designed to combat a range of serious conditions, including various cancers, immune system dysfunctions, and infectious diseases. The company’s operations are segmented into three distinct areas: Cell Therapy, Degenerative Disease, and BioBanking. Their therapeutic pipeline features several key candidates: CYCART-19, a placental-derived CAR-T therapy, currently in Phase I trials for B-cell malignancies; CYNK-001, an unmodified natural killer (NK) cell also from placental sources, advancing through Phase I trials for acute myeloid leukemia and Phase I/IIa trials for glioblastoma multiforme and COVID-19; and CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I for HER2+ gastric and gastroesophageal cancers. Furthermore, two mesenchymal-like adherent stromal cell candidates, APPL-001 and PDA-002 (both derived from placentas), are in pre-clinical development for Crohn's disease and facioscapulohumeral muscular dystrophy, respectively. In addition to its therapeutic development, Celularity is involved in commercial activities, offering surgical and wound care products like Biovance and Interfyl through sales and licensing agreements. The company also specializes in collecting stem cells from umbilical cords and placentas, providing storage services under its LifebankUSA brand. Founded in 2016, Celularity Inc. maintains its headquarters in Florham Park, New Jersey.

Florham Park, NJ

115 employees

www.celularity.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Robert Joseph Hariri

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+22.14%
30D Total Return	+1.79%
YTD Total Return	+54.05%
1Y Total Return	-19.72%
3Y Total Return	-18.97%
5Y Total Return	-97.60%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+54.05%
2025	-46.63%
2024	-15.79%
2023	-80.85%
2022	-74.80%
2021	-53.45%
2020

CAGR TTM	-19.63%
CAGR 3Y	-6.77%
CAGR 5Y	-52.57%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	3.13
PE Ratio Avg TTM	11.46
PE Ratio Avg 3Y	11.53
Current VS TTM Avg	-72.68%
Current VS 3Y Avg	-72.86%
Current VS 5Y Avg	-72.86%

All Metrics

CELU Valuation Metrics

CELU Stock Price Metrics

CELU Dividend Metrics

CELU Growth Rate Metrics

CELU Discounted Cash Flow Metrics

CELU Returns By Period

CELU Yearly Returns

CELU Average Annual Returns By Period (CAGR)

CELU Revenue Metrics

CELU PE Ratio Metrics

CELU PS Ratio Metrics

CELU PB Ratio Metrics

CELU Price to Free Cash Flow Ratio Metrics

CELU Debt to Equity Ratio Metrics

CELU PEG Ratio Metrics

CELU FCF Yield

CELU Earnings Yield

CELU EBITDA Yield

CELU OCF Yield

CELU EV/EBIT Ratio Metrics

CELU EV/EBITDA Ratio Metrics

CELU EV/Assets Ratio Metrics

CELU EV/Sales Ratio Metrics

CELU Current Ratio Metrics

CELU Quick Ratio Metrics

CELU ROIC Metrics

CELU Return on Assets Metrics

CELU Return on Equity Metrics

CELU Net Profit Margin Metrics

CELU Gross Profit Margin Metrics

CELU Tax Rate Metrics

PS Ratio	2.73
PS Ratio Avg TTM	0.88
PS Ratio Avg 3Y	1.63
Current VS TTM Avg	+209.26%
Current VS 3Y Avg	+67.47%
Current VS 5Y Avg	-37.36%

PB Ratio	9.97
PB Ratio Avg TTM	3.27
PB Ratio Avg 3Y	1.65
Current VS TTM Avg	+205.31%
Current VS 3Y Avg	+503.08%
Current VS 5Y Avg	+509.66%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	(1.71)
Debt/Equity Ratio Avg TTM	(4.31)
Debt/Equity Ratio Avg 3Y	0.27
Current VS TTM Avg	+60.29%
Current VS 3Y Avg	-740.50%
Current VS 5Y Avg	-982.41%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	31.95%
Earnings Yield Avg TTM	10.93%
Earnings Yield Avg 3Y	10.84%
Current VS TTM Avg	+192.35%
Current VS 3Y Avg	+194.73%
Current VS 5Y Avg	+194.73%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	1.12
Ev/Assets Ratio Avg TTM	0.76
Ev/Assets Ratio Avg 3Y	0.81
Current VS TTM Avg	+47.01%
Current VS 3Y Avg	+38.60%
Current VS 5Y Avg	+51.13%

Ev/Sales Ratio	5.89
Ev/Sales Ratio Avg TTM	2.40
Ev/Sales Ratio Avg 3Y	4.16
Current VS TTM Avg	+145.73%
Current VS 3Y Avg	+41.48%
Current VS 5Y Avg	-11.55%

Current Ratio	0.09
Current Ratio Avg TTM	0.21
Current Ratio Avg 3Y	0.26
Current VS TTM Avg	-56.65%
Current VS 3Y Avg	-65.39%
Current VS 5Y Avg	-79.16%

Quick Ratio	0.08
Quick Ratio Avg TTM	0.16
Quick Ratio Avg 3Y	0.20
Current VS TTM Avg	-48.89%
Current VS 3Y Avg	-58.17%
Current VS 5Y Avg	-80.29%

ROIC	(192.99%)
ROIC Avg 3Y	(99.26%)
ROIC Avg 5Y	(69.95%)
Current VS 3Y Avg	-94.42%
Current VS 5Y Avg	-175.92%
Current VS 10Y Avg	-223.69%

ROA	(71.66%)
ROA Avg TTM	(15.59%)
ROA Avg 3Y	(14.33%)
Current VS TTM Avg	-359.75%
Current VS 3Y Avg	-399.96%
Current VS 5Y Avg	-724.80%

ROE	N/A
ROE Avg TTM	(447.34%)
ROE Avg 3Y	(236.17%)
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Net Profit Margin	(375.77%)
Net Profit Margin Avg TTM	(322.63%)
Net Profit Margin Avg 3Y	(198.43%)
Current VS TTM Avg	-16.47%
Current VS 3Y Avg	-89.37%
Current VS 5Y Avg	+10.93%

Gross Profit Margin	79.62%
Gross Pft Margin Avg TTM	84.06%
Gross Pft Margin Avg 3Y	63.47%
Current VS TTM Avg	-5.28%
Current VS 3Y Avg	+25.45%
Current VS 5Y Avg	+75.98%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.05%
Tax Rate Avg 5Y	(0.03%)
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	+100.00%
Current VS 10Y Avg	-100.00%